The ASEAN Alliance of Health Supplement Associations (AAHSA) is planning to run a study that looks at the potential health care cost savings coming from the use of specific dietary supplements, such as omega-3, vitamin D, probiotics, and magnesium.
Multi-strain probiotics obtained from the human gut have shown promising effects in reducing irritable bowel syndrome (IBS) disease severity, and should be further studied as a potential treatment for the condition, say Korean researchers.
Australia company Anatara Lifesciences is trialling the use of a bromelain-containing supplement in patients suffering from irritable bowel syndrome (IBS).
Malaysian firm Davos Life Science is interested to find out the efficacy of tocotrienols in alleviating the symptoms of irritable bowel syndrome (IBS) in humans, following a recent successful mice study.
A probiotic strain marketed by Lallemand Health Solutions has been granted new health claims related to Irritable Bowel Syndrome (IBS) by Canadian health authority Health Canada.
